Profile - To The Moon

宁检国

.宁检国，初中毕业，务农，为了实现财富自由

Posts · 18Posts · 18
Following · 0Following · 0
Followers · 0Followers · 0

- 宁检国宁检国
  ·2025-11-07
  $腾盛博药-B(02137)$
  1.29K Comment
  1
  Share
  Report
- 宁检国宁检国
  ·2023-05-08
  ..[可爱] [愤怒] [生气] [惊讶] [白眼] [龇牙] [白眼] ........n bb n.
  Baixinan-B's intraday change, its share price plunged 5.08% to HK$8.620 in afternoon trading
  2023年04月20日下午盘13时42分，百心安-B股票出现波动，股价急速下挫5.08%。截至发稿，该股报8.620港元/股，成交量57.86万股，换手率0.24%，振幅6.61%。资金方面，该股资金流入199.558万港元，流出268.074万港元。百心安-B股票所在的医疗保健设备行业中，整体跌幅为0.31%。消息层面，截至13时42分，百心安-B股票正面舆情新闻比例53.85%。
  Baixinan-B's intraday change, its share price plunged 5.08% to HK$8.620 in afternoon trading
  2.01K Comment
  Like
  Share
  Report
- 宁检国宁检国
  ·2023-05-08
  pO[惊讶] [生气] [傲娇] [可爱] [可爱]
  Baixinan-B's intraday change, its share price plunged 5.08% to HK$8.620 in afternoon trading
  2023年04月20日下午盘13时42分，百心安-B股票出现波动，股价急速下挫5.08%。截至发稿，该股报8.620港元/股，成交量57.86万股，换手率0.24%，振幅6.61%。资金方面，该股资金流入199.558万港元，流出268.074万港元。百心安-B股票所在的医疗保健设备行业中，整体跌幅为0.31%。消息层面，截至13时42分，百心安-B股票正面舆情新闻比例53.85%。
  Baixinan-B's intraday change, its share price plunged 5.08% to HK$8.620 in afternoon trading
  2.59K Comment
  Like
  Share
  Report
- 宁检国宁检国
  ·2023-05-08
  ！！？lm？！：
  Sorry, this post has been deleted
  2.20K Comment
  Like
  Share
  Report
No following yet

Most Discussed

{"i18n":{"language":"en_US"},"isCurrentUser":false,"userPageInfo":{"id":"3585913375465016","uuid":"3585913375465016","gmtCreate":1622822862408,"gmtModify":1624874431927,"name":"宁检国","pinyin":"njgningjianguo","introduction":"","introductionEn":null,"signature":".宁检国，初中毕业，务农，为了实现财富自由","avatar":"https://static.tigerbbs.com/75b5e702e5659469bb94c9e6adbcb55d","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":2,"headSize":174,"tweetSize":18,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":1,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-3","templateUuid":"1026c425416b44e0aac28c11a0848493","name":" Tiger Idol","description":"Join the tiger community for 1500 days","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.04.23","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"972123088c9646f7b6091ae0662215be-2","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Master Trader","description":"Total number of securities or futures transactions reached 100","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.10.23","exceedPercentage":"80.05%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.29","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":497570304114744,"gmtCreate":1762500081459,"gmtModify":1762500084149,"author":{"id":"3585913375465016","authorId":"3585913375465016","name":"宁检国","avatar":"https://static.tigerbbs.com/75b5e702e5659469bb94c9e6adbcb55d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3585913375465016","idStr":"3585913375465016"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02137\">$腾盛博药-B(02137)$ &nbsp;</a>","listText":"<a href=\"https://laohu8.com/S/02137\">$腾盛博药-B(02137)$ &nbsp;</a>","text":"$腾盛博药-B(02137)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/497570304114744","isVote":1,"tweetType":1,"viewCount":1288,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":656156366,"gmtCreate":1683536400956,"gmtModify":1683536400956,"author":{"id":"3585913375465016","authorId":"3585913375465016","name":"宁检国","avatar":"https://static.tigerbbs.com/75b5e702e5659469bb94c9e6adbcb55d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3585913375465016","idStr":"3585913375465016"},"themes":[],"title":"","htmlText":"..[可爱]&nbsp;[愤怒]&nbsp;[生气]&nbsp;[惊讶]&nbsp;[白眼]&nbsp;[龇牙]&nbsp;[白眼]&nbsp;........n bb&nbsp; &nbsp; &nbsp; &nbsp; n.","listText":"..[可爱]&nbsp;[愤怒]&nbsp;[生气]&nbsp;[惊讶]&nbsp;[白眼]&nbsp;[龇牙]&nbsp;[白眼]&nbsp;........n bb&nbsp; &nbsp; &nbsp; &nbsp; n.","text":"..[可爱] [愤怒] [生气] [惊讶] [白眼] [龇牙] [白眼] ........n bb n.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/656156366","repostId":"2328760665","repostType":2,"repost":{"id":"2328760665","kind":"news","pubTimestamp":1681969340,"share":"https://ttm.financial/m/news/2328760665?lang=en_US&edition=fundamental","pubTime":"2023-04-20 13:42","market":"hk","language":"zh","title":"Baixinan-B's intraday change, its share price plunged 5.08% to HK$8.620 in afternoon trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2328760665","media":"自选股智能写手","summary":"2023年04月20日下午盘13时42分，百心安-B股票出现波动，股价急速下挫5.08%。截至发稿，该股报8.620港元/股，成交量57.86万股，换手率0.24%，振幅6.61%。资金方面，该股资金流入199.558万港元，流出268.074万港元。百心安-B股票所在的医疗保健设备行业中，整体跌幅为0.31%。消息层面，截至13时42分，百心安-B股票正面舆情新闻比例53.85%。","content":"<p><html><body><article>At 13:42 pm on April 20, 2023,<a href=\"https://laohu8.com/S/02185\">Baixin'an-B</a>(02185.hk) stock was volatile, and its share price plunged 5.08%. As of press time, the stock was reported at HK$ 8.620/share, with a trading volume of 578,600 shares.<span>Turnover rate</span>0.24%, with an amplitude of 6.61%.</p><p>In terms of funds, the stock had an inflow of HK$1,99558 million and an outflow of HK$2,680,74 million.</p><p>Recent earnings data shows that the stock achieved<span>OPERATING INCOME</span>No data yet,<span>Net Profit</span>-HK$229 million,<span>Earnings per share</span>-HK$0.94,<span>Gross profit</span>No data yet, P/E-9.20 times.</p><p>In terms of institutional rating, at present, no institution has made a \"buy, hold and sell\" recommendation for the stock.</p><p>In the healthcare equipment industry, where Baixinan-B stock is located, the overall decline was 0.31%. Among its related stocks,<a href=\"https://laohu8.com/S/02297\">Runmed-B</a>、<a href=\"https://laohu8.com/S/00876\">Kaisa Health</a>、<a href=\"https://laohu8.com/S/01612\">Yongsheng Medical</a>Related stocks with large increases and large amplitudes are<a href=\"https://laohu8.com/S/01931\">Huajian Medical</a>、<a href=\"https://laohu8.com/S/09955\">Zhiyun Health</a>、<a href=\"https://laohu8.com/S/01066\">Weigao Shares</a>With amplitudes of 10.96%, 8.73%, and 6.87%, respectively.</p><p>Baixin'an-B Company Profile: Shanghai Baixin'an Biotechnology Co., Ltd. is a Chinese company mainly engaged in interventional medicine. The company's main business is the research and development and production of interventional cardiovascular devices. The company's key products include fully degradable stents (BRS) and renal nerve blockade (RDN). The company's products are mainly used to meet medical needs for the treatment of coronary and peripheral arterial diseases and hypertension.</p><p>At the news level, as of 13: 42, the proportion of positive public opinion news of Baixinan-B stock was 53.85%.</p><p>(The above contents are optional stocks<a href=\"https://laohu8.com/S/5RE.SI\">smart</a>The machine writer Money Call is completed. It is only used as a reference for users to read the market, not as a basis for transactions.)</p><p></article></body></html></p>","source":"tencent","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Baixinan-B's intraday change, its share price plunged 5.08% to HK$8.620 in afternoon trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBaixinan-B's intraday change, its share price plunged 5.08% to HK$8.620 in afternoon trading\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">自选股智能写手</strong><span class=\"h-time small\">2023-04-20 13:42</span>\n</p>\n</h4>\n</header>\n<article>\n<p><html><body><article>At 13:42 pm on April 20, 2023,<a href=\"https://laohu8.com/S/02185\">Baixin'an-B</a>(02185.hk) stock was volatile, and its share price plunged 5.08%. As of press time, the stock was reported at HK$ 8.620/share, with a trading volume of 578,600 shares.<span>Turnover rate</span>0.24%, with an amplitude of 6.61%.</p><p>In terms of funds, the stock had an inflow of HK$1,99558 million and an outflow of HK$2,680,74 million.</p><p>Recent earnings data shows that the stock achieved<span>OPERATING INCOME</span>No data yet,<span>Net Profit</span>-HK$229 million,<span>Earnings per share</span>-HK$0.94,<span>Gross profit</span>No data yet, P/E-9.20 times.</p><p>In terms of institutional rating, at present, no institution has made a \"buy, hold and sell\" recommendation for the stock.</p><p>In the healthcare equipment industry, where Baixinan-B stock is located, the overall decline was 0.31%. Among its related stocks,<a href=\"https://laohu8.com/S/02297\">Runmed-B</a>、<a href=\"https://laohu8.com/S/00876\">Kaisa Health</a>、<a href=\"https://laohu8.com/S/01612\">Yongsheng Medical</a>Related stocks with large increases and large amplitudes are<a href=\"https://laohu8.com/S/01931\">Huajian Medical</a>、<a href=\"https://laohu8.com/S/09955\">Zhiyun Health</a>、<a href=\"https://laohu8.com/S/01066\">Weigao Shares</a>With amplitudes of 10.96%, 8.73%, and 6.87%, respectively.</p><p>Baixin'an-B Company Profile: Shanghai Baixin'an Biotechnology Co., Ltd. is a Chinese company mainly engaged in interventional medicine. The company's main business is the research and development and production of interventional cardiovascular devices. The company's key products include fully degradable stents (BRS) and renal nerve blockade (RDN). The company's products are mainly used to meet medical needs for the treatment of coronary and peripheral arterial diseases and hypertension.</p><p>At the news level, as of 13: 42, the proportion of positive public opinion news of Baixinan-B stock was 53.85%.</p><p>(The above contents are optional stocks<a href=\"https://laohu8.com/S/5RE.SI\">smart</a>The machine writer Money Call is completed. It is only used as a reference for users to read the market, not as a basis for transactions.)</p><p></article></body></html></p>\n<div class=\"bt-text\">\n\n\n<p> source：<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230420134220846f1c43&s=b\">自选股智能写手</a></p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK1100":"医疗保健设备","02185":"百心安-B"},"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230420134220846f1c43&s=b","is_english":false,"share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","article_id":"2328760665","content_text":"2023年04月20日下午盘13时42分，百心安-B（02185.hk）股票出现波动，股价急速下挫5.08%。截至发稿，该股报8.620港元/股，成交量57.86万股，换手率0.24%，振幅6.61%。资金方面，该股资金流入199.558万港元，流出268.074万港元。最近的财报数据显示，该股实现营业收入数据暂无，净利润-2.29亿港元，每股收益-0.94港元，毛利数据暂无，市盈率-9.20倍。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。百心安-B股票所在的医疗保健设备行业中，整体跌幅为0.31%。其相关个股中，润迈德-B、佳兆业健康、永胜医疗涨幅较大，振幅较大的相关个股有华检医疗、智云健康、威高股份，振幅分别为10.96%、8.73%、6.87%。百心安-B公司简介：上海百心安生物技术有限公司是一家主要从事介入医疗的中国公司。该公司的主营业务是介入式心血管装置的研发和生产。该公司的主要产品包括全降解支架(BRS)和肾神经阻断(RDN)。该公司的产品主要用于满足治疗冠状、外周动脉疾病及高血压等的医疗需求。消息层面，截至13时42分，百心安-B股票正面舆情新闻比例53.85%。（以上内容为自选股智能机器写手Money Call完成，仅作为用户看盘参考，不作为交易依据。）","news_type":1,"symbols_score_info":{"02185":0.9}},"isVote":1,"tweetType":1,"viewCount":2014,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":656156987,"gmtCreate":1683536281150,"gmtModify":1683536281150,"author":{"id":"3585913375465016","authorId":"3585913375465016","name":"宁检国","avatar":"https://static.tigerbbs.com/75b5e702e5659469bb94c9e6adbcb55d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3585913375465016","idStr":"3585913375465016"},"themes":[],"title":"","htmlText":"pO[惊讶]&nbsp;[生气]&nbsp;[傲娇]&nbsp;[可爱]&nbsp;[可爱]&nbsp;","listText":"pO[惊讶]&nbsp;[生气]&nbsp;[傲娇]&nbsp;[可爱]&nbsp;[可爱]&nbsp;","text":"pO[惊讶] [生气] [傲娇] [可爱] [可爱]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/656156987","repostId":"2328760665","repostType":2,"repost":{"id":"2328760665","kind":"news","pubTimestamp":1681969340,"share":"https://ttm.financial/m/news/2328760665?lang=en_US&edition=fundamental","pubTime":"2023-04-20 13:42","market":"hk","language":"zh","title":"Baixinan-B's intraday change, its share price plunged 5.08% to HK$8.620 in afternoon trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2328760665","media":"自选股智能写手","summary":"2023年04月20日下午盘13时42分，百心安-B股票出现波动，股价急速下挫5.08%。截至发稿，该股报8.620港元/股，成交量57.86万股，换手率0.24%，振幅6.61%。资金方面，该股资金流入199.558万港元，流出268.074万港元。百心安-B股票所在的医疗保健设备行业中，整体跌幅为0.31%。消息层面，截至13时42分，百心安-B股票正面舆情新闻比例53.85%。","content":"<p><html><body><article>At 13:42 pm on April 20, 2023,<a href=\"https://laohu8.com/S/02185\">Baixin'an-B</a>(02185.hk) stock was volatile, and its share price plunged 5.08%. As of press time, the stock was reported at HK$ 8.620/share, with a trading volume of 578,600 shares.<span>Turnover rate</span>0.24%, with an amplitude of 6.61%.</p><p>In terms of funds, the stock had an inflow of HK$1,99558 million and an outflow of HK$2,680,74 million.</p><p>Recent earnings data shows that the stock achieved<span>OPERATING INCOME</span>No data yet,<span>Net Profit</span>-HK$229 million,<span>Earnings per share</span>-HK$0.94,<span>Gross profit</span>No data yet, P/E-9.20 times.</p><p>In terms of institutional rating, at present, no institution has made a \"buy, hold and sell\" recommendation for the stock.</p><p>In the healthcare equipment industry, where Baixinan-B stock is located, the overall decline was 0.31%. Among its related stocks,<a href=\"https://laohu8.com/S/02297\">Runmed-B</a>、<a href=\"https://laohu8.com/S/00876\">Kaisa Health</a>、<a href=\"https://laohu8.com/S/01612\">Yongsheng Medical</a>Related stocks with large increases and large amplitudes are<a href=\"https://laohu8.com/S/01931\">Huajian Medical</a>、<a href=\"https://laohu8.com/S/09955\">Zhiyun Health</a>、<a href=\"https://laohu8.com/S/01066\">Weigao Shares</a>With amplitudes of 10.96%, 8.73%, and 6.87%, respectively.</p><p>Baixin'an-B Company Profile: Shanghai Baixin'an Biotechnology Co., Ltd. is a Chinese company mainly engaged in interventional medicine. The company's main business is the research and development and production of interventional cardiovascular devices. The company's key products include fully degradable stents (BRS) and renal nerve blockade (RDN). The company's products are mainly used to meet medical needs for the treatment of coronary and peripheral arterial diseases and hypertension.</p><p>At the news level, as of 13: 42, the proportion of positive public opinion news of Baixinan-B stock was 53.85%.</p><p>(The above contents are optional stocks<a href=\"https://laohu8.com/S/5RE.SI\">smart</a>The machine writer Money Call is completed. It is only used as a reference for users to read the market, not as a basis for transactions.)</p><p></article></body></html></p>","source":"tencent","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Baixinan-B's intraday change, its share price plunged 5.08% to HK$8.620 in afternoon trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBaixinan-B's intraday change, its share price plunged 5.08% to HK$8.620 in afternoon trading\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">自选股智能写手</strong><span class=\"h-time small\">2023-04-20 13:42</span>\n</p>\n</h4>\n</header>\n<article>\n<p><html><body><article>At 13:42 pm on April 20, 2023,<a href=\"https://laohu8.com/S/02185\">Baixin'an-B</a>(02185.hk) stock was volatile, and its share price plunged 5.08%. As of press time, the stock was reported at HK$ 8.620/share, with a trading volume of 578,600 shares.<span>Turnover rate</span>0.24%, with an amplitude of 6.61%.</p><p>In terms of funds, the stock had an inflow of HK$1,99558 million and an outflow of HK$2,680,74 million.</p><p>Recent earnings data shows that the stock achieved<span>OPERATING INCOME</span>No data yet,<span>Net Profit</span>-HK$229 million,<span>Earnings per share</span>-HK$0.94,<span>Gross profit</span>No data yet, P/E-9.20 times.</p><p>In terms of institutional rating, at present, no institution has made a \"buy, hold and sell\" recommendation for the stock.</p><p>In the healthcare equipment industry, where Baixinan-B stock is located, the overall decline was 0.31%. Among its related stocks,<a href=\"https://laohu8.com/S/02297\">Runmed-B</a>、<a href=\"https://laohu8.com/S/00876\">Kaisa Health</a>、<a href=\"https://laohu8.com/S/01612\">Yongsheng Medical</a>Related stocks with large increases and large amplitudes are<a href=\"https://laohu8.com/S/01931\">Huajian Medical</a>、<a href=\"https://laohu8.com/S/09955\">Zhiyun Health</a>、<a href=\"https://laohu8.com/S/01066\">Weigao Shares</a>With amplitudes of 10.96%, 8.73%, and 6.87%, respectively.</p><p>Baixin'an-B Company Profile: Shanghai Baixin'an Biotechnology Co., Ltd. is a Chinese company mainly engaged in interventional medicine. The company's main business is the research and development and production of interventional cardiovascular devices. The company's key products include fully degradable stents (BRS) and renal nerve blockade (RDN). The company's products are mainly used to meet medical needs for the treatment of coronary and peripheral arterial diseases and hypertension.</p><p>At the news level, as of 13: 42, the proportion of positive public opinion news of Baixinan-B stock was 53.85%.</p><p>(The above contents are optional stocks<a href=\"https://laohu8.com/S/5RE.SI\">smart</a>The machine writer Money Call is completed. It is only used as a reference for users to read the market, not as a basis for transactions.)</p><p></article></body></html></p>\n<div class=\"bt-text\">\n\n\n<p> source：<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230420134220846f1c43&s=b\">自选股智能写手</a></p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK1100":"医疗保健设备","02185":"百心安-B"},"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230420134220846f1c43&s=b","is_english":false,"share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","article_id":"2328760665","content_text":"2023年04月20日下午盘13时42分，百心安-B（02185.hk）股票出现波动，股价急速下挫5.08%。截至发稿，该股报8.620港元/股，成交量57.86万股，换手率0.24%，振幅6.61%。资金方面，该股资金流入199.558万港元，流出268.074万港元。最近的财报数据显示，该股实现营业收入数据暂无，净利润-2.29亿港元，每股收益-0.94港元，毛利数据暂无，市盈率-9.20倍。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。百心安-B股票所在的医疗保健设备行业中，整体跌幅为0.31%。其相关个股中，润迈德-B、佳兆业健康、永胜医疗涨幅较大，振幅较大的相关个股有华检医疗、智云健康、威高股份，振幅分别为10.96%、8.73%、6.87%。百心安-B公司简介：上海百心安生物技术有限公司是一家主要从事介入医疗的中国公司。该公司的主营业务是介入式心血管装置的研发和生产。该公司的主要产品包括全降解支架(BRS)和肾神经阻断(RDN)。该公司的产品主要用于满足治疗冠状、外周动脉疾病及高血压等的医疗需求。消息层面，截至13时42分，百心安-B股票正面舆情新闻比例53.85%。（以上内容为自选股智能机器写手Money Call完成，仅作为用户看盘参考，不作为交易依据。）","news_type":1,"symbols_score_info":{"02185":0.9}},"isVote":1,"tweetType":1,"viewCount":2591,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":656194066,"gmtCreate":1683511294756,"gmtModify":1683511294756,"author":{"id":"3585913375465016","authorId":"3585913375465016","name":"宁检国","avatar":"https://static.tigerbbs.com/75b5e702e5659469bb94c9e6adbcb55d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3585913375465016","idStr":"3585913375465016"},"themes":[],"title":"","htmlText":"！！？lm？！&nbsp;：","listText":"！！？lm？！&nbsp;：","text":"！！？lm？！ ：","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/656194066","repostId":"2330393679","repostType":2,"isVote":1,"tweetType":1,"viewCount":2198,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"following","isTTM":true}